AOD9604 allows researchers to investigate targeted metabolic signaling processes using a single-compound peptide formulation
Trusted by 625,000+ families since 2016
An interaction between parkin and its substrate -synuclein is a crucial regulatory component of dopaminergic neuron degeneration, loss-of-function mutations in PARK2 usually cause early-onset autosomal recessive PD (Kitada et al., 1998), whereas disease-associated mutations in -synuclein are usually associated with autosomal dominant PD (Polymeropoulos et al., 1997)
FDAs introductory briefing document states that the agency does not intend to issue a final determination until it has considered input from the advisory committee process and finalized its reviews
Dopamine supplementation would be evident, but this hydrophilic neurotransmitter does not cross the BBB and cannot enter the CNS due to brain endothelial tight junctions, active brain endothelial metabolism and lack of transporters [5]
It is required for the synthesis of DNA and the maintenance of the myelin sheath that protects nerves
